Psychiatry Weekly: psychiatric news, information, education


Psychiatry Weekly is the first weekly psychiatric news, information, and education service in the country for clinicians providing mental health services. The service includes a weekly poster distributed to hospitals nationwide, a weekly e-letter, and this website, which is consistently updated with features, CME content, and breaking news. Psychiatry Weekly is a joint venture between MBL Communications, Inc., publishers of Primary Psychiatry and CNS Spectrums, and Physician’s Weekly, LLC, the leading medical news service for acute care hospitals for over 25 years.


Relationship Between Residual Symptoms of Depression and Self-reported Cognitive Impairment Paola Pedrelli, PhD Despite the availability of numerous antidepressants, many patients with major depressive disorder receiving optimal pharmacologic treatment do not remit while still experiencing residual symptoms.


Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis Norman Sussman, MD When I returned from my holiday vacation recently, I saw the following headline: “Popular Drugs May Help Only Severe Depression.” Even more sensationalist pronouncements could be found on cable news websites. The average reader’s impression, quite possibly, is that here is further evidence that antidepressant medication is less effective than psychiatrists and pharmaceutical companies contend.


Treatment-Resistant Depression -- Part III: Switching Antidepressants vs. Conventional Augmentation Strategies George I. Papakostas, MD This is the final installment of a three-part series covering treatment-resistant depression (TRD). Part I, by Dr. John O'Reardon, and Part II, by Dr. Michael Thase, cover the scope and clinical spectrum of TRD, and augmentation strategies, respectively. Browse our library of free CME programs.